{"disease":{"id":"calciphylaxis","name":"calciphylaxis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03146793","title":"The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Centre Hospitalier St Esprit","has_results":false},{"nct_id":"NCT02854046","title":"Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04195906","title":"Phase 3 Study of SNF472 for Calciphylaxis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Sanifit Therapeutics S. A.","has_results":true},{"nct_id":"NCT05633121","title":"Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Association ECHO","has_results":false},{"nct_id":"NCT03150420","title":"A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"Hope Pharmaceuticals","has_results":false},{"nct_id":"NCT06283589","title":"The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT04592640","title":"Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03319914","title":"Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate","phase":"","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Hope Pharmaceuticals","has_results":false},{"nct_id":"NCT02527213","title":"Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"American Regent, Inc.","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}